Correlation Between Sumitomo Dainippon and Esperion Therapeutics

Can any of the company-specific risk be diversified away by investing in both Sumitomo Dainippon and Esperion Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sumitomo Dainippon and Esperion Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sumitomo Dainippon Pharma and Esperion Therapeutics, you can compare the effects of market volatilities on Sumitomo Dainippon and Esperion Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sumitomo Dainippon with a short position of Esperion Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sumitomo Dainippon and Esperion Therapeutics.

Diversification Opportunities for Sumitomo Dainippon and Esperion Therapeutics

0.0

Correlation Coefficient

Sumitomo Dainippon  Esperion Therapeutics

Pay attention - limited upside

The 3 months correlation between Sumitomo and Esperion is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Sumitomo Dainippon Pharma and Esperion Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Esperion Therapeutics and Sumitomo Dainippon is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sumitomo Dainippon Pharma are associated (or correlated) with Esperion Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Esperion Therapeutics has no effect on the direction of Sumitomo Dainippon i.e., Sumitomo Dainippon and Esperion Therapeutics go up and down completely randomly.

Pair Corralation between Sumitomo Dainippon and Esperion Therapeutics

If you would invest  426.00  in Esperion Therapeutics on December 1, 2024 and sell it today you would lose (256.00) from holding Esperion Therapeutics or give up 60.09% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Sumitomo Dainippon Pharma  vs.  Esperion Therapeutics

Sumitomo Dainippon Pharma

Risk-Adjusted Performance

Very Weak

Over the last 90 days Sumitomo Dainippon Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Sumitomo Dainippon is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Esperion Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Esperion Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unfluctuating performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Sumitomo Dainippon and Esperion Therapeutics

The main advantage of trading using opposite Sumitomo Dainippon and Esperion Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sumitomo Dainippon position performs unexpectedly, Esperion Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Esperion Therapeutics will offset losses from the drop in Esperion Therapeutics' long position.

The idea behind Sumitomo Dainippon Pharma and Esperion Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.